ELISA (USA)
InBios offers a wide range of high-performing ELISA kits to support diagnosis of emerging infectious diseases of global importance. Our ELISAs are developed with superior quality reagents and manufactured in our FDA registered facility in Seattle, WA, USA.
Babesiosis
- IgG to Babesia microti (RUO)
Chagas
- IgG to Trypanosoma cruzi (RUO)
COVID-19
- Neutralizing Antibody for SARS-CoV-2 (FDA EUA/CE)
- IgM (FDA EUA/CE)
- IgG (FDA EUA/CE)
Filariasis
- IgG4 (RUO)
Scrub Typhus
Strongyloidiasis
- IgG (In Development)